CY1106823T1 - Δισκιο που περιλαμβανει πολυμερες με ικανοτητα συνδεσης με φωσφορικη ενωση - Google Patents

Δισκιο που περιλαμβανει πολυμερες με ικανοτητα συνδεσης με φωσφορικη ενωση

Info

Publication number
CY1106823T1
CY1106823T1 CY20071101107T CY071101107T CY1106823T1 CY 1106823 T1 CY1106823 T1 CY 1106823T1 CY 20071101107 T CY20071101107 T CY 20071101107T CY 071101107 T CY071101107 T CY 071101107T CY 1106823 T1 CY1106823 T1 CY 1106823T1
Authority
CY
Cyprus
Prior art keywords
phosphate
binding capacity
containing polymers
tablet containing
phosphate binding
Prior art date
Application number
CY20071101107T
Other languages
English (en)
Inventor
Katsuya Matsuda
Ryuji Kubota
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of CY1106823T1 publication Critical patent/CY1106823T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Παρουσιάζεται δισκίο που περιλαμβάνει πολυμερές με ικανότητα σύνδεσης με φωσφορική ένωση, το οποίο έχει μέσο μέγεθος σωματιδίων 400 μm ή μικρότερο, περιέχει σωματίδια με μέγεθος 500 μm ή μικρότερο σε αναλογία 90% ή μεγαλύτερη και έχει περιεχόμενο σε υγρασία 1-14%, μαζί με κρυσταλλική κυτταρίνη και/ή χαμηλά υποκατεστημένη υδροξυπροπυλοκυτταρίνη καθώς και μέθοδος παρασκευής αυτού. Το δισκίο με πολυμερές με ικανότητα σύνδεσης με φωσφορική ένωση σύμφωνα με την παρούσα εφεύρεση περιέχει το δραστικό συστατικό σε υψηλή αναλογία, έχει εξαιρετική ικανότητα σύνδεσης με φωσφορική ένωση και υφίσταται γρήγορη αποικοδόμηση εντός όξινης έως ουδέτερης περιοχής ενώ σχεδόν δεν επηρεάστηκε από την δύναμη ανάδευσης. Επομένως, είναι ένα εξαιρετικό παρασκεύασμα ικανό να ρυθμίζει αλλαγές στη βιοδιαθεσιμότητα λόγω γαστρεντερικών κινήσεων και της τιμής pΗ.
CY20071101107T 1997-04-04 2007-08-23 Δισκιο που περιλαμβανει πολυμερες με ικανοτητα συνδεσης με φωσφορικη ενωση CY1106823T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8658197 1997-04-04
EP98911187A EP0997148B1 (en) 1997-04-04 1998-04-03 Phosphate-binding polymer preparations

Publications (1)

Publication Number Publication Date
CY1106823T1 true CY1106823T1 (el) 2012-05-23

Family

ID=13890981

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101107T CY1106823T1 (el) 1997-04-04 2007-08-23 Δισκιο που περιλαμβανει πολυμερες με ικανοτητα συνδεσης με φωσφορικη ενωση

Country Status (16)

Country Link
US (2) US6383518B1 (el)
EP (2) EP0997148B1 (el)
JP (2) JP2009173687A (el)
KR (1) KR100456202B1 (el)
CN (1) CN1180782C (el)
AT (2) ATE364377T1 (el)
AU (1) AU726142B2 (el)
CA (1) CA2286003C (el)
CY (1) CY1106823T1 (el)
DE (2) DE69837945T2 (el)
DK (1) DK1304104T3 (el)
ES (2) ES2201463T3 (el)
HK (2) HK1027506A1 (el)
PT (1) PT1304104E (el)
TW (1) TW592727B (el)
WO (1) WO1998044933A1 (el)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
JP3718341B2 (ja) 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
ATE286386T1 (de) * 1999-10-19 2005-01-15 Genzyme Corp Direktkomprimierter tablettenkern auf polymerbasis
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (ja) 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
WO2002066543A1 (en) 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
AU2002252632B2 (en) 2001-04-18 2004-09-23 Genzyme Corporation Low salt forms of polyallylamine
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
CA2444046C (en) 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
FR2827771B1 (fr) * 2001-07-25 2003-10-24 Apis Spheromont Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
TWI231760B (en) * 2001-12-20 2005-05-01 Chugai Pharmaceutical Co Ltd Coated lozenge and manufacturing method thereof
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2601236A1 (en) * 2005-03-16 2006-09-21 Usv Limited An improved process for the preparation of crosslinked polyallylamine polymer
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
GB0601899D0 (en) * 2006-01-31 2006-03-08 Ineos Silicas Ltd Compositions
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US7749536B2 (en) 2006-02-14 2010-07-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
PT1818048E (pt) * 2006-02-14 2009-03-11 Teva Pharma Formulações farmacêuticas de polímeros aminados alifáticos e processos para a sua produção
EP2016114A2 (en) * 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
EP2049014A2 (en) * 2006-07-18 2009-04-22 Genzyme Corporation Amine dendrimers
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
BRPI0717008A2 (pt) * 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
EP2152277A1 (en) * 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
WO2009078958A1 (en) * 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
CA2749397A1 (en) * 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
EA024699B1 (ru) * 2009-10-22 2016-10-31 Синтон Б. В. Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
WO2016135065A1 (en) * 2015-02-23 2016-09-01 Amneal Pharmaceuticals Company Gmbh Process for granulating sevelamer carbonate
AU2017388956A1 (en) 2016-12-28 2019-07-11 Fujifilm Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
JP7018451B2 (ja) * 2017-10-16 2022-02-10 富士フイルム株式会社 高リン血症治療剤および粒子
WO2019078197A1 (ja) 2017-10-16 2019-04-25 富士フイルム株式会社 高リン血症治療剤
JP2019182818A (ja) * 2018-04-17 2019-10-24 ライオン株式会社 舌苔除去用の口腔内崩壊錠及び舌苔除去方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
DE3776116D1 (de) 1986-12-30 1992-02-27 American Cyanamid Co Zusammensetzung die ein polycarbophil enthaelt.
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
JPH02286621A (ja) * 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
JPH0413627A (ja) 1990-04-27 1992-01-17 Mitsubishi Kasei Corp 経口コレステロール低下剤
JP2609022B2 (ja) 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH06157325A (ja) 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
TW272942B (el) 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3836893B2 (ja) * 1995-01-24 2006-10-25 アボットジャパン株式会社 ポリカルボフィルカルシウム含有製剤
TW438608B (en) 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤

Also Published As

Publication number Publication date
US6696087B2 (en) 2004-02-24
PT1304104E (pt) 2007-07-27
KR20010005980A (ko) 2001-01-15
EP1304104B1 (en) 2007-06-13
ES2287215T3 (es) 2007-12-16
CA2286003C (en) 2007-06-05
JP5681156B2 (ja) 2015-03-04
CN1254287A (zh) 2000-05-24
DE69816082D1 (de) 2003-08-07
CA2286003A1 (en) 1998-10-15
ES2201463T3 (es) 2004-03-16
DE69837945D1 (de) 2007-07-26
CN1180782C (zh) 2004-12-22
US6383518B1 (en) 2002-05-07
AU6522398A (en) 1998-10-30
KR100456202B1 (ko) 2004-11-09
ATE364377T1 (de) 2007-07-15
HK1027506A1 (en) 2001-01-19
JP2013010803A (ja) 2013-01-17
EP0997148A1 (en) 2000-05-03
DE69837945T2 (de) 2008-02-21
US20020122786A1 (en) 2002-09-05
ATE244013T1 (de) 2003-07-15
EP1304104A3 (en) 2003-11-12
EP0997148A4 (en) 2000-05-03
AU726142B2 (en) 2000-11-02
JP2009173687A (ja) 2009-08-06
EP0997148B1 (en) 2003-07-02
DE69816082T2 (de) 2004-04-15
WO1998044933A1 (fr) 1998-10-15
DK1304104T3 (da) 2007-07-16
HK1055387A1 (en) 2004-01-09
TW592727B (en) 2004-06-21
EP1304104A2 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
CY1106823T1 (el) Δισκιο που περιλαμβανει πολυμερες με ικανοτητα συνδεσης με φωσφορικη ενωση
AR041114A1 (es) Particulas polimericas que tienen grupos pendientes seleccionados y composicion preparada a partir de las mismas
CY1110475T1 (el) Πολυμερη συνδεσης ανιοντος και χρησεις αυτών
NO20002547L (no) Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav
RS50397B (sr) Farmaceutska smeša
ATE487472T1 (de) Nicht-gelatinöse kapseln
CA2306257A1 (en) 5-azaquinoxaline-based compounds and modulation of serine/threonine protein kinase function
ATE47715T1 (de) Stabile salze von sam mit polyanionen.
DE69414904D1 (de) Silikat-Polymer enthaltende pharmazeutische Zusammensetzungen
NO20010065D0 (no) Zwitterioniske derivater og anvendelse av egenskapene til vandige suspensjoner
AU626086B2 (en) Polymeric polyalkyl-1-oxa-diazaspirodecanes
DK0404582T3 (da) Gellangummilim
EP0361763A3 (en) Papermaking filler compositions
MY122873A (en) Resist compositions with polymers having pendant groups containing plural acid labile moieties.
BR0004367A (pt) Pelota e processo de fabricação da mesma.
DE69942980D1 (de) Hilfsmittelzusammensetzung zur papierherstellung
BR9915787A (pt) Processo para a preparação de uma rede polimérica
BR0101067A (pt) Combinações poliméricas de amido usadas na fabricação de papel
ATE207914T1 (de) Alpha-liponsäure in kristalliner form
ES2093286T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
EA199900918A2 (ru) Способ получения монодисперсных гелеобразных катионитов
WO1990005211A3 (de) Papier-, karton- oder pappenartiger werkstoff und verfahren zu dessen herstellung
IT1301969B1 (it) Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
ES2062072T3 (es) Clorofibras con un caracter antiseptico permanente y procedimiento para obtenerlas.
TH25009A (th) " ฟิล์มโพลีโพพิลันที่ถูกจัดเรียงให้มีความต้านทางทางความชื้นสูง "